EPISODE · Aug 18, 2021 · 20 MIN
Evan Levine, PsyBio Therapeutics
from Psychedelic Spotlight Podcast · host David Flores, Global Trac Solutions Inc., PsyBio Therapeutics, Evan Levine, Psychedelic Spotlight
In this episode of the Psychedelic Spotlight podcast, we spotlight Evan Levine, Chairman & CEO of PsyBio Therapeutics, an intellectual property driven biotechnology company developing novel formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health issues and other disorders.In our conversation with Evan, we get the opportunity to learn more about the unique therapeutic solutions PsyBio is currently focused on developing, and we gain a more concise understanding of the value the company is establishing for itself through its evolving intellectual property portfolio of biosynthetic psychoactive compounds.*To learn more about PsyBio Therapeutics and the work they’re doing, visit their website: PsyBioLife.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on August 10, 2021.
What this episode covers
Chairman & CEO of PsyBio Therapeutics, Evan Levine, shares why PsyBio doesn't use magic mushrooms to make psilocybin medicine.
NOW PLAYING
Evan Levine, PsyBio Therapeutics
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m